| Product Code: ETC7536778 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India antimycotic drugs market import shipment demonstrated a significant decline with a CAGR of -17.2% from 2020 to 2024. However, there was a remarkable upsurge in growth between 2023 and 2024, with a growth rate of 313.5%. This indicates a period of substantial recovery and potential market resurgence after a period of contraction.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Antimycotic Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Antimycotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Antimycotic Drugs Market - Industry Life Cycle |
3.4 India Antimycotic Drugs Market - Porter's Five Forces |
3.5 India Antimycotic Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 India Antimycotic Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 India Antimycotic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Antimycotic Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 India Antimycotic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Antimycotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of fungal infections in India |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of fungal infections |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in the country |
4.3 Market Restraints |
4.3.1 Lack of access to quality healthcare services in rural areas |
4.3.2 High cost associated with advanced antimycotic drugs |
4.3.3 Presence of counterfeit or substandard antimycotic drugs in the market |
5 India Antimycotic Drugs Market Trends |
6 India Antimycotic Drugs Market, By Types |
6.1 India Antimycotic Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 India Antimycotic Drugs Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 India Antimycotic Drugs Market Revenues & Volume, By Azoles, 2021- 2031F |
6.1.4 India Antimycotic Drugs Market Revenues & Volume, By Polyenes, 2021- 2031F |
6.1.5 India Antimycotic Drugs Market Revenues & Volume, By Allylamines, 2021- 2031F |
6.2 India Antimycotic Drugs Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 India Antimycotic Drugs Market Revenues & Volume, By Amphotericin B, 2021- 2031F |
6.2.3 India Antimycotic Drugs Market Revenues & Volume, By Antifungal Therapy for Invasive and Serious Mycoses, 2021- 2031F |
6.3 India Antimycotic Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Antimycotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Antimycotic Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 India Antimycotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Antimycotic Drugs Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 India Antimycotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Antimycotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 India Antimycotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 India Antimycotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Antimycotic Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Antimycotic Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 India Antimycotic Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 India Antimycotic Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 India Antimycotic Drugs Market Import-Export Trade Statistics |
7.1 India Antimycotic Drugs Market Export to Major Countries |
7.2 India Antimycotic Drugs Market Imports from Major Countries |
8 India Antimycotic Drugs Market Key Performance Indicators |
8.1 Number of reported cases of fungal infections in India |
8.2 Rate of adoption of new antimycotic drugs in the market |
8.3 Investment in research and development of antimycotic drugs |
8.4 Percentage of healthcare facilities equipped to diagnose and treat fungal infections |
8.5 Patient adherence to prescribed antimycotic treatment regimens |
9 India Antimycotic Drugs Market - Opportunity Assessment |
9.1 India Antimycotic Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 India Antimycotic Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 India Antimycotic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Antimycotic Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 India Antimycotic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Antimycotic Drugs Market - Competitive Landscape |
10.1 India Antimycotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Antimycotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here